SEC FORM 4

SEC FORM 4SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arima Anastasios

(Last)

(First)

(Middle)

1092 CONFROY DRIVE

(Street)

SOUTH BOSTON

VIRGINIA

24592

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IPERIONX Ltd [ IPX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares⁽¹⁾								12,206,782	D
Restricted Stock Units								738,576⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
American Depository Shares (ADS)⁽³⁾	⁽⁴⁾							⁽⁴⁾	⁽⁴⁾	IPX Ordinary Shares⁽¹⁾⁽⁴⁾	128,000⁽⁴⁾		12,800⁽⁴⁾	D
Performance Rights (A$6)	$6⁽⁵⁾							04/10/2029	04/10/2030	IPX Ordinary Shares⁽¹⁾	435,806		435,806	D
Performance Rights (A$7)	$7⁽⁵⁾							04/10/2029	04/10/2030	IPX Ordinary Shares⁽¹⁾	435,806		435,806	D
Performance Rights (A$8)	$8⁽⁵⁾							04/10/2029	04/10/2030	IPX Ordinary Shares⁽¹⁾	435,806		435,806	D
Performance Rights (A$18)	$18⁽⁵⁾	04/02/2026		A		237,944		04/02/2030	04/02/2031	IPX Ordinary Shares⁽¹⁾	237,944	⁽⁶⁾	237,944	D
Options (A$18)	$18⁽⁵⁾	04/02/2026		A		564,759		04/02/2030	04/02/2031	IPX Ordinary Shares⁽¹⁾	564,759	$18⁽⁷⁾	564,759	D
Options (A$22)	$22⁽⁵⁾	04/02/2026		A		639,205		04/02/2030	04/02/2031	IPX Ordinary Shares⁽¹⁾	639,205	$22⁽⁷⁾	639,205	D

Explanation of Responses:

1. Ordinary Shares are traded on the Australian Stock Exchange (ASX).

2. 318,666 vest in December 2026; 419,910 vest in April 2028.

3. American Depository Shares are traded on the Nasdaq.

4. One ADS is equivalent and exchangeable into ten ordinary shares.

5. Australian Dollars

6. Each performance right is convertible into one ordinary share after performance criteria have been met. Performance criteria are (1) four years of continuous service through 04/02/2030, and (2) IPX stock price on the ASX reaching a thirty-day volume-weighted average price (VWAP) of A$18.00.

7. Each option confers the right to purchase one ordinary share at the conversion price.

	Samantha Birdsong Manning	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

SEC Form 4 filed by Arima Anastasios